Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)
Clinical trial NCT02337283 · COMPLETED
Trial details
- NCT number
- NCT02337283
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-15
- Primary completion
- 2015-11-16
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.